Tacalyx extends seed funding round to raise over €14m
Cancer-focused biotech Tacalyx has extended its seed financing round to raise over €14m ($15.03m).
Cancer-focused biotech Tacalyx has extended its seed financing round to raise over €14m ($15.03m).
What's Your Reaction?
